United States · FDA National Drug Code directory
GIVLAARI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71336-1001_942492a0-de6e-4c31-8b9c-d259f808d821
- Product NDC
- 71336-1001
- Form
- INJECTION, SOLUTION
- Composition / generic term
- givosiran sodium
- Labeler
- Alnylam Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20191212
- Source listing expiry
- 20261231
Source-listed ingredients
- GIVOSIRAN SODIUM — 189 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (71336-1001-1) / 1 mL in 1 VIAL, SINGLE-USE · 71336-1001-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →